Accuray (ARAY) Competitors $1.57 -0.02 (-1.26%) Closing price 04:00 PM EasternExtended Trading$1.60 +0.02 (+1.59%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDTShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Accuray vs. Its Competitors Orthofix Medical Surmodics AngioDynamics Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Do analysts recommend ARAY or OFIX? Accuray presently has a consensus price target of $5.00, suggesting a potential upside of 218.47%. Orthofix Medical has a consensus price target of $21.50, suggesting a potential upside of 44.20%. Given Accuray's higher possible upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, ARAY or OFIX? Accuray has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Is ARAY or OFIX more profitable? Accuray has a net margin of -0.35% compared to Orthofix Medical's net margin of -15.29%. Accuray's return on equity of -4.92% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-0.35% -4.92% -0.58% Orthofix Medical -15.29%-25.43%-14.46% Which has preferable earnings and valuation, ARAY or OFIX? Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$458.51M0.39-$1.59M-$0.02-78.50Orthofix Medical$799.49M0.74-$126M-$3.17-4.70 Do insiders and institutionals have more ownership in ARAY or OFIX? 64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 1.3% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor ARAY or OFIX? In the previous week, Orthofix Medical had 6 more articles in the media than Accuray. MarketBeat recorded 9 mentions for Orthofix Medical and 3 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.43 beat Accuray's score of 1.21 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accuray 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAccuray and Orthofix Medical tied by winning 8 of the 16 factors compared between the two stocks. Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$176.90M$6.79B$5.79B$10.15BDividend YieldN/A1.23%5.69%4.61%P/E Ratio-78.5025.5274.5925.92Price / Sales0.3962.89454.0285.55Price / Cash34.7721.6337.0859.91Price / Book2.185.0012.156.29Net Income-$1.59M$176.38M$3.28B$270.85M7 Day Performance3.97%1.00%0.98%3.35%1 Month Performance6.08%3.19%7.20%6.40%1 Year Performance-25.94%12.30%63.06%28.21% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray4.7101 of 5 stars$1.57-1.3%$5.00+218.5%-19.3%$176.90M$458.51M-78.501,040Positive NewsHigh Trading VolumeOFIXOrthofix Medical3.4884 of 5 stars$14.70+1.0%$21.50+46.3%-13.8%$574.64M$799.49M-4.641,616News CoveragePositive NewsSRDXSurmodics4.6105 of 5 stars$32.93+1.7%$43.00+30.6%-17.7%$462.96M$126.08M-26.77450Positive NewsANGOAngioDynamics4.1675 of 5 stars$10.90+1.6%$19.00+74.3%+47.7%$436M$292.50M-13.13760Positive NewsRMTIRockwell Medical3.7982 of 5 stars$1.59-1.9%$4.00+151.6%-58.8%$55.78M$87.97M-26.50300Short Interest ↑Gap UpRSLSReShape Lifesciences0.0139 of 5 stars$3.16-1.4%N/A-99.7%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeABTAbbott Laboratories4.8837 of 5 stars$132.27-0.5%$144.47+9.2%+13.7%$231.38B$41.95B16.58114,000Positive NewsISRGIntuitive Surgical4.9359 of 5 stars$470.00+0.7%$595.95+26.8%-7.1%$167.36B$8.35B65.5515,638Positive NewsBSXBoston Scientific4.7882 of 5 stars$108.14+0.9%$117.79+8.9%+26.1%$158.87B$16.75B64.3753,000Trending NewsAnalyst ForecastAnalyst RevisionSYKStryker4.9366 of 5 stars$393.12+0.2%$430.10+9.4%+6.1%$149.98B$22.60B52.0753,000Positive NewsMDTMedtronic4.9317 of 5 stars$92.91+0.0%$102.14+9.9%+4.2%$119.16B$33.54B25.5995,000Positive News Related Companies and Tools Related Companies OFIX Alternatives SRDX Alternatives ANGO Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARAY) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
